Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, is reviewing pharmacy programs run by AbbVie Inc and Teva Pharmaceuticals Industries Ltd after finding questionable practices at Valeant Pharmaceuticals International Inc’s partner pharmacy, Philidor Rx Services. Express Scripts and other big managers of prescription medicine benefits for health plans said on Thursday they would no longer work with Philidor as concerns mount that Philidor was improperly directing drugs made
Swatch Group (UHR.VX) expects to launch a smartwatch that can be used to make payments in Switzerland next spring, Chief Executive Nick Hayek said in an interview with a Swiss newspaper published on Saturday. The watch is likely to use a pre-paid system, Hayek told Finanz und Wirtschaft, unlike a version launched in China this month that can be used like a debit card. Hayek said this was because the
Swatch Group (UHR.VX) expects to launch a smartwatch that can be used to make payments in Switzerland next spring, Chief Executive Nick Hayek said in an interview with a Swiss newspaper published on Saturday. The watch is likely to use a pre-paid system, Hayek told Finanz und Wirtschaft, unlike a version launched in China this month that can be used like a debit card. Hayek said this was because the
It’s no secret we do things we know we shouldn’t. We overeat, gamble away our savings and live like tomorrow will never come. One reason, two Nobel laureates argue, is that there are plenty of businesses …
Happy Halloween! America’s been having fun dissecting and transplanting body parts onto Adam Smith theories since 1776, molding a Frankenstein monster into an economy for narcissist billionaires.
Join Midday Movers live now for the latest news on the markets, the economy and the biggest stories of the day.
Oil prices were little changed on Friday, awaiting U.S. rig count data that would indicate potential North American crude production, as a global supply glut continued to weigh on the market despite unseasonably strong demand for U.S. oil products. For the week, both Brent and U.S. crude showed gains after Wednesday’s 6 percent rally helped the two benchmarks snap two previous weeks of losses. The rally was driven by sharper-than-expected
Stocks with big buyback programs are falling behind the S&P 500, and one technician says the underperformance is starting to look like 2000 and 2007.
Some of the world’s largest energy companies and investment banks are becoming more pessimistic about the ability of crude oil pricing to reach even $60 a barrel next year, reporting steep losses as they take hits on projects that no longer make financial sense. Continued oversupply means that next year, Brent crude prices will average $58 a barrel and West Texas Intermediate, the U.S. oil benchmark, will average $54 a
Hedge fund mogul William Ackman told his investors on Friday that he was confident in his bet on Valeant Pharmaceuticals (VRX.N)(VRX.TO) but faulted the company for a weak response to fraud allegations that have sunk its stock. Valeant shares were last down 4.3 percent at $106.74 in New York trading. Valeant denied any wrongdoing in a conference call on Monday.
